Rouault - © 2006 Nature Publishing Group

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology PERSPECTIVE The role of iron regulatory proteins in mammalian iron homeostasis and disease Tracey A Rouault Iron regulatory proteins 1 and 2 (IRP1 and IRP2) are mammalian proteins that register cytosolic iron concentrations and posttranscriptionally regulate expression of iron metabolism genes to optimize cellular iron availability. In iron-deficient cells, IRPs bind to iron-responsive elements (IREs) found in the mRNAs of ferritin, the transferrin receptor and other iron metabolism transcripts, thereby enhancing iron uptake and decreasing iron sequestration. IRP1 registers cytosolic iron status mainly through an iron-sulfur switch mechanism, alternating between an active cytosolic aconitase form with an iron-sulfur cluster ligated to its active site and an apoprotein form that binds IREs. Although IRP2 is homologous to IRP1, IRP2 activity is regulated primarily by iron-dependent degradation through the ubiquitinproteasomal system in iron-replete cells. Targeted deletions of IRP1 and IRP2 in animals have demonstrated that IRP2 is the chief physiologic iron sensor. The physiological role of the IRP-IRE system is illustrated by (i) hereditary hyperferritinemia cataract syndrome, a human disease in which ferritin L-chain IRE mutations interfere with IRP binding and appropriate translational repression, and (ii) a syndrome of progressive neurodegenerative disease and anemia that develops in adult mice lacking IRP2. The early death of mouse embryos that lack both IRP1 and IRP2 suggests a central role for IRP-mediated regulation in cellular viability. Iron is indispensable for the function of many prosthetic groups, including heme and iron-sulfur clusters, and animals have accordingly developed sophisticated systems to maintain iron homeostasis. Cellular iron uptake, distribution and export must be tightly regulated, as insufficient iron concentrations impair the function of numerous iron proteins, whereas excess free iron can oxidize and damage the protein, nucleic acid and lipid contents of cells. In humans, iron deficiency is the most common cause of anemia in the world, and it interferes significantly with normal cognitive development in children. Conversely, the iron overload observed in common diseases such as hemochromatosis and thalassemia causes liver and heart failure. Thus, organisms and individual cells must regulate iron metabolism to ensure that sufficient iron is provided to supply heme, the iron-sulfur prosthetic groups of Tracey A. Rouault is in the Cell Biology and Metabolism Branch, National Institute of Child Health and Human Development, Building 18T, Room 101, National Institutes of Health, Bethesda, Maryland 20892, USA. e-mail: trou@helix.nih.gov Published online 18 July 2006; doi:10.1038/nchembio807 406 mitochondrial respiratory-chain complexes, and cellular iron enzymes such as ribonucleotide reductase1. In mammals, dietary iron uptake across the duodenal mucosa is regulated through the expression of the intramembrane metal transporters ferroportin and divalent metal transporter 1 (DMT1) in response to signals from the liver1,2. After iron has traversed the intestinal mucosa, it enters the bloodstream and binds tightly to transferrin3. Most cells can effectively control iron uptake by regulating the amount of transferrin receptor (TfR1)4 that is expressed on their plasma membranes. In addition, cells regulate expression of the cytosolic iron-sequestration protein ferritin5 as well as numerous other proteins to optimize availability of cytosolic iron. In mammalian cells, the IRPs (which are derived from a duplicated gene pair) register metal availability mainly through direct interactions with iron in the cytosol6,7. In iron-depleted cells, IRPs bind to IREs, RNA elements within mRNAs that encode ferritin, transferrin receptor and many other transcripts, and this IRP binding represses translation (Fig. 1a) or prolongs mRNA half-life (Fig. 1b) depending on where the IRP binds on the mRNA7,8. The IRP-IRE regulatory system enables cells to rapidly adjust concentrations of available cytosolic iron and thereby optimize the functioning of numerous iron-dependent cellular components. IRPs bind to IREs in iron metabolism transcripts IREs are highly conserved IRP binding sites that are found in the 5′ untranslated region (UTR) of transcripts that encode the H and L ferritin subunits (H, highly expressed in heart; L, highly expressed in liver), in the 3′ UTR of TfR1 and in several other iron metabolism genes8. IRP1 and IRP2 are ubiquitously expressed mammalian members of the aconitase gene family9 that have adapted to sense cytosolic iron concentrations and accordingly modify gene expression. Aconitases are enzymes found in virtually all organisms that convert citrate to isocitrate through the intermediate cis-aconitate in the citric acid cycle, the central cycle of intermediary metabolism. In aconitases, a cubane iron-sulfur cluster is ligated by three cysteines within the enzymatic active site cleft, and the fourth iron of the cubane cluster binds substrate10. IRP1 and IRP2 are highly related to the aconitase family, but only IRP1 has retained its ability to function as an aconitase, whereas IRP2 apparently lost its aconitase activity sometime during evolution6,7. In cells that are depleted of iron, each IRP responds by binding to IREs (Fig. 1). By binding to a single IRE located in the 5 UTR of an mRNA, the IRP prevents translation of the mRNA (Fig. 1a), whereas by binding to IREs in the 3′ UTR, the IRP protects the TfR transcript from endonucleolytic cleavage and degradation (Fig. 1b). In cells that are iron replete, IRPs do not bind IREs, and ferritin and other transcripts VOLUME 2 NUMBER 8 AUGUST 2006 NATURE CHEMICAL BIOLOGY © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology PERSPECTIVE that have an IRE in the 5′ UTR are freely translated. Conversely, the TfR exporter ferroportin30. IREs have also been found in the 3′ UTR of transcript undergoes cleavage by an uncharacterized endonuclease at a one isoform of the ferrous iron transporter, DMT1 (ref. 31), and in specific site flanked by IREs in the 3′ UTR, and the cleavage products are mammalian glycolate oxidase32 (also known as hydroxyacid oxidase subsequently degraded. 2), but it is not yet clear whether these IREs contribute to regulation of Acquisition of IRE binding ability by IRP1 may have occurred through expression of DMT1 (ref. 33) or glycolate oxidase34. natural selection: accumulation of IRP1 lacking an iron-sulfur cluster in iron-deficient cells could have allowed the apoprotein to bind to RNA IRE mutations cause hyperferritinemia and cataract syndrome stem-loop structures of appropriate size and shape that appeared in the Members of families with mutations in the IRE of the ferritin L chain highly mutable UTRs of some mRNAs. When expression from transcripts have high serum concentrations of ferritin and are prone to development encoding iron metabolism proteins was favorably affected, IRP binding of early-onset cataracts. Since the initial description of the hereditary could have resulted in selective retention of the IRE within the transcript. Selection of IREs may be an ongoing evolutionary process, given that a Ferritin mRNA One IRE in 5´ UTR UTR sequences are not constrained by having to encode protein. IRE stem loops have conserved sequence features, including a six-member loop in which 5´ 3´ the sequence of the first five residues is usually AUG CAGUG, and upper and lower stems that are separated from one another by an unpaired +Fe –Fe cytosine on the 5′ side (Fig. 2)11,12. Fully functional IREs are likely to have longer lower stems IRP than those depicted here, perhaps to allow more extensive interactions of the RNA with IREbinding proteins (that is, IRPs) or to stabilize AAAAAA 40s the conformation of the IRE stem loop13,14. Base pairing between loop residues 1 and 5 of the IRE IRE, occupied by IRP, inhibiting translation stabilizes the loop structure11, and in vitro bindinitiation ing studies have shown that other residues may functionally substitute for the C1-G5 base pair of the loop if base pairing is maintained15,16. 60s IRE, unoccupied, allowing The structure of the IRE seems to function polysome formation and as a ‘molecular ruler’ that preserves a specific increased ferritin synthesis distance and spatial orientation between IRE residues that may directly and specifically contact IRE-binding proteins. Possible candidates b TfR mRNA Five IREs in 3´ UTR for such specific contacts include the G3 of the loop, which has an unusual syn conformation AAAAAA in the NMR structure, and the bulge cytidine Protein 3´ 5´ 11, that separates the upper and lower stems coding though substitution of other residues in the bulge position is most likely compatible with high-affinity binding17, and it is possible that –Fe IRP1 and IRP2 have individual specific targets that vary from the consensus sequence15,16,18. +Fe IRP Ferritin IREs have a more complex bulge and Endonuclease a lower stem, and they are often represented cleavage site AAAAAA with a three-residue bulge19,20, although data Protein 16 and analysis of human from selection studies coding AAAAAA mutations14,21 strongly imply that the middle Protein residue of the proposed bulge forms a base pair coding with a residue on the opposite side of the stem One or more IREs, occupied (Fig. 3). by IRP, protecting mRNA from rate-determining After initial characterization of the IRE IRE, unoccupied, rendering step, mRNA degradation mRNA susceptible to stem-loop structure22,23, IREs have been found an endonuclease in the 5′ UTRs of the erythocytic form of aminolevulinic acid synthase (eALAS, which Figure 1 Ferritin translation and TfR mRNA degradation are regulated by IRP binding. (a) In catalyzes the first step in heme synthesis)24,25, iron-depleted cells, IRP binding to the IRE in the 5′ UTR interferes with translational initiation. 26–28, in mammalian mitochondrial aconitase (b) Binding of IRPs to IREs in the TfR 3′ UTR protects the transcript from endonucleolytic cleavage in the succinate dehydrogenase b subunit of and degradation. The arrow marks the site at which an unknown endonuclease cleaves the TfR Drosophila melanogaster29 and in the iron transcript in iron-replete cells when it is unprotected by IRP binding6. NATURE CHEMICAL BIOLOGY VOLUME 2 NUMBER 8 AUGUST 2006 407 © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology PERSPECTIVE hyperferritinemia cataract syndrome (HHCS)35, numerous familial mutations have been described21,36, and the degree of hyperferritinemia and cataract severity has been correlated with the degree to which the mutation impairs IRP binding14. Because patients with HHCS have high concentrations of ferritin in their blood, candidates for HHCS are easily identified by blood tests, and many mutations of the ferritin L-chain IRE have been described, some of which are depicted in Figure 3. Mutations of the ferritin L-chain IRE confer a dominant phenotype, because IRP binding to transcripts from the mutant allele is partially or completely attenuated, and ferritin L-chain expression increases even though translation of the other ferritin L-chain allele is repressed normally. Thus, HHCS illustrates the importance of ferritin translational repression in normal physiology. according to the dimensions and shape determined in its NMR structure solution)11. The crystal structure of the holoprotein shows a closed conformation that does not allow substrates to access the active site, unless dynamic motion of the structure allows small interdomain shifts within the holoprotein, as was previously predicted10. Notably, reseachers have identified a partially connected network of hydrophilic cavities in the crystal structure of IRP1 at the domain interfacial region, and Dupuy et al. have proposed that these channel-like structural features may be involved in guiding the movement of substrates and products to and from the active site, perhaps aided by a small rotation of domain 4. The IRE has a shape much like that of the portion of domain 4 that faces domains 1–3, thereby enabling the IRE to potentially substitute for domain 4 and interact with the portions of domains 1–3 that form the active site cleft. In addition, electrostatic modeling of domain 4 has revealed numerous positive charges on the domain 4 surface that normally faces the active site cleft, and these positively charged residues may bind to the negatively charged phosphate backbone of the IRE in the IRP-IRE complex. Thus, one side of the IRE appears to mimic the size and conformational features of domain 4, allowing it to substitute for domain 4 by forming favorable contacts with domains 1–3, while on the opposite side of the IRE, charge interactions may allow the IRE to bind to the displaced fourth domain. Crystallization of the IRP-IRE complex60 and solution of the crystal structure should allow a detailed characterization of the RNA binding site of IRP1. Both IRP1 and IRP2 bind IREs with high affinity in iron-depleted cells, as demonstrated in many different cell lines by gel-shift assays that use radiolabeled IRE to reveal binding activity. Efforts to elucidate the mechanisms by which IRPs register cytosolic iron concentrations have been ongoing since their initial characterization. The structure of IRP1 and formation of the IRP-IRE complex In mammalian cells, IRP1 and IRP2 bind to IREs and modify expression of ferritin, TfR and other transcripts in iron-depleted cells. Investigators originally purified and cloned IRP1 by using its ability to bind IREs as an assay37–40, and they were able to clone IRP2 simultaneously with IRP1 because of sequence homology37, although IRP2’s role as a second IREbinding protein was not recognized for several years41,42. IRP1 and IRP2 are derived from duplicated mammalian genes, and the human forms are 56% identical to one another. IRP1 is a functional aconitase that interconverts citrate and isocitrate in the cytosol43,44. This reaction is also catalyzed in the mitochondrial matrix by mitochondrial aconitase, a key enzyme of the citric acid cycle that is encoded by a separate gene45. IRP1 contains a [4Fe-4S] cluster that is ligated to the active site by binding of Cys437, Cys503 and Cys506 to three iron atoms of the cluster, whereas the fourth iron binds solvent and substrate10,44. The recent solution of the crystal structure of IRP1 (ref. 46) reveals that the structure of IRP1 is very similar to that of mitochondrial aconi- IRP1 has an iron-sulfur switch that determines its activity tase47, as was predicted on the basis of sequence conservation between Researchers recognized a possible mechanism for regulation of the IREIRP1 and mitochondrial aconitase10. When IRP1 loses its iron-sulfur binding activity of IRP1 when it became apparent that IRP1 alternates cluster, it acquires the ability to bind to IREs with high affinity, and between two major forms: the cytosolic aconitase form, which contains when the cysteines that ligate the iron-sulfur cluster are mutagenized, a [4Fe-4S] cluster bound to the enzymatic active site and which does not IRP1 becomes a constitutive IRE-binding protein48,49 that stabilizes TfR mRNA and represses ferritin synthesis in cells50,51. The a b G A iron-sulfur cluster of IRP1 is readily destabi52,53, including nitric oxide54 lized by oxidants U C Hexanucleotide Loop and hydrogen peroxide55, and cluster degradaloop G tion produces apoprotein that binds IREs and lacks iron and sulfur (Fig. 4a)44,56. Upper stem Numerous cross-linking, mutagenesis and Upper stem (5 bp) Bulge C chemical modification studies have indicated that the IRE binding site of IRP1 overlaps Unpaired cytosine with the aconitase active site48,49,57. Given the known dimensions of several RNA stem-loop 5´ Lower stem structures, it was hypothesized that IRE bindLower stem ing could occur within the active site cleft of IRP1 if the fourth domain of the protein, which 3´ is connected to domains one through three by a flexible hinge linker, were to swing open. Figure 2 IRE secondary structure. (a) A schematic of a consensus IRE is shown. The IRE contains a Further mutagenesis58 and footprinting of the six-residue loop, usually with the sequence CAGYGX, where Y represents U or C and X represents any IRE-IRP interactions59 indicated that residues residue except G. The upper and lower stems are composed of base pairs (bp) of variable sequence near the entrance to the active site cleft on both (N-N′) that are separated by an unpaired C. (b) In the NMR solution structure of a consensus IRE, a bp sides are important in IRE binding. Figure 4b forms between C1 and G5, and A2 stacks on G5 in the conserved loop sequence CAGUGX (modified from ref. 11, courtesy of K. Addess, with permission). The helical upper and lower stems have an shows the structure of IRP1 with an intact iron- A-form conformation, and both the bulge C and the unpaired G residue at position 3 in the loop are 46 as well as another view of the sulfur cluster disordered in solution. The 5-bp upper stem most likely functions as a molecular ruler that orients and protein in which domain 4 has been displaced correctly distances the bulge C from residues in the loop, allowing flexible residues to participate in to accommodate docking of the IRE (created sequence-specific interactions between the IRE and IRPs. 408 VOLUME 2 NUMBER 8 AUGUST 2006 NATURE CHEMICAL BIOLOGY © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology PERSPECTIVE bind IREs, and the apoprotein form, which lacks an iron-sulfur cluster and binds IREs. It is now well accepted that the ‘iron-sulfur cluster switch’ is an important determinant of whether IRP1 has cytosolic aconitase or IRE-binding activity1,6,7,53,61. Synthesis of the iron-sulfur cluster requires iron, sulfur and dedicated biosynthetic proteins, whereas cluster turnover results mainly from cluster oxidation and spontaneous degradation. The strength and capacity of the forces that enhance new synthesis relative to that of the forces that favor cluster degradation determine the way in which IRP1 functions (Fig. 4a). Thus, to understand IRP1 function, it is important to understand the factors involved in assembly and turnover of iron-sulfur clusters in mammalian cells. Mammalian iron-sulfur cluster assembly Assembly of iron-sulfur clusters is a complex process involving many enzymes and scaffold proteins62,63, and mammalian iron-sulfur clusters are synthesized by homologs of bacterial and yeast proteins64 (Fig. 5). Through alternative splicing and alternative initiation, mammalian cells generate cytosolic isoforms of iron-sulfur cluster assembly proteins that directly facilitate assembly of the iron-sulfur cluster of IRP1 in the cytosol65,66. Mammalian iron-sulfur assembly proteins known to be present in both mitochondria and cytosol include the cysteine desulfurase that provides sulfur in the correct oxidation state67, the primary scaffold on which nascent clusters are assembled (iron sulfur cluster U assembly protein)68 and the scaffold protein NFU (a protein required for maturation of FeS clusters of nitrogenase in nitrogen-fixing bacteria)69. Other proteins involved in iron-sulfur cluster assembly include (i) frataxin, which may serve as an iron donor, (ii) reducing proteins such as ferredoxin and glutaredoxin and (iii) chaperone and co-chaperone proteins, which facilitate protein folding reactions when nascent clusters are transferred from scaffold to recipient proteins (Fig. 5). Clearly, iron-sulfur cluster assembly requires sufficient sources of sulfur and iron, and deficiency of iron-sulfur cluster assembly proteins, cysteine or iron can potentially inhibit iron-sulfur cluster assembly. Expression of the iron-sulfur cluster assembly scaffold protein ISCU decreases in iron-deficient cells65, thereby offering the possibility that the iron-sulfur switch of IRP1 may be regulated not only through iron availability, but also through regulation of the expression of iron-sulfur cluster assembly proteins. There are several recent examples in which impairment of the ironsulfur cluster assembly machinery activates the IRE binding activity of IRP1 in a physiologically relevant setting. In zebrafish, mutations in glutaredoxin 5 (an enzyme important in iron-sulfur cluster biogenesis)70,71 cause heme deficiency, profound anemia and early death. Rescue experiments indicate that the first step of heme biosynthesis is repressed by binding of IRP1 to the eALAS transcript of zebrafish, which, as in mammals, contains an IRE in its 5′ UTR. The zebrafish studies establish an important genetic linkage between heme biosynthesis and the iron-sulfur cluster biogenesis of IRP1 (ref. 72), and they constitute an important independent confirmation of the iron-sulfur switch model of IRP1 regulation73. In mammalian cells, knockdown of ISCU markedly reduces mitochondrial aconitase activity and shifts IRP1 from the aconitase form to the IRE-binding form. Moreover, specific knockdown of the cytosolic ISCU isoform shows that the ironsulfur switch of IRP1 can be activated by interfering directly with the cytosolic iron-sulfur cluster assembly machinery65. However, it is not yet clear how many iron-sulfur assembly proteins are present in mammalian cytosol. Iron-sulfur cluster disassembly The state of the iron-sulfur switch of IRP1 depends not only on synthesis of the iron-sulfur cluster but also on the rate of cluster turnover. The iron-sulfur cluster of IRP1 can be oxidized and destabilized by NATURE CHEMICAL BIOLOGY VOLUME 2 NUMBER 8 AUGUST 2006 oxygen, nitric oxide and peroxynitrite74, and it can be indirectly disassembled by hydrogen peroxide–mediated activation of a signaling pathway75. In macrophages in which IRP1 could be exposed to endogenously generated reactive oxygen species and nitric oxide, there is little apparent cytosolic aconitase activity76. Notably, silencing of cytosolic superoxide dismutase in Drosophila melanogaster results in activation of cytosolic aconitase but not mitochondrial aconitase, whereas silencing of mitochondrial superoxide dismutase (SOD) decreases mitochondrial but not cytosolic aconitase activity77, implying that superoxide can be an important cause of intracellular iron-sulfur cluster disassembly. Similarly, in mice with cytosolic SOD deficiency, cytosolic aconitase activity decreases as IRE binding activity concomitantly increases78. In yeast with cytosolic SOD deficiency, iron-sulfur enzymes in both the cytosol and the mitochondria have decreased activity79. Thus, results in fly, yeast and mouse model systems implicate superoxide as a potentially potent cause for disassembly of the iron-sulfur clusters of both mitochondrial and cytosolic aconitases. Verona ( +41) Paris 1 ( +41) London 1 ( +41) London 2 ( +36) Paris 2 ( +32) Pavia 1 ( +32) Pavia 2 (+18 and +22) (+1) Figure 3 Mutations of the ferritin L-chain IRE cause HHCS. Multiple mutations in the ferritin L-chain transcript interfere with IRP binding, resulting in derepression of ferritin L-chain translation, high serum ferritin concentrations and cataract formation. The ferritin L-chain transcriptional start site (+1) is shown, and the first 77 nucleotides are depicted in an extended stem-loop structure with residues numbered in sequence14. Multiple mutations are labeled to show the nucleotide change, along with the name of the city in which patients affected by the mutation were first identified. Mutations affect the loop and the upper and lower stems, including a G32U substitution in the Paris 2 mutation and a G32A substitution in the Pavia 1 mutation (shown), which is also the site of a recently described G32C mutation21 that affects the potential base pair formation of G32 within a region of the ferritin IRE that is often represented as an unpaired residue within a three-nucleotide ‘bulge’14. 409 PERSPECTIVE a Bulged C Fe2+ released © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology O2 or other oxidants in solvent –Fe +Fe +Fe-S cluster assemby enzymes G b Domain 1 (2–240) Domain 1 (2–240) Domain 2 (241–368) 2 Domain 2 (241–368) 2 Linker (593–654) Linker (593–654) 889 Domain 3 (369–592) 889 Domain 4 (655–889) Domain 3 (369–592) IRE [4Fe-4S] Figure 4 The iron-sulfur switch of IRP1. (a) A cartoon showing the iron-sulfur switch of IRP1. IRP1 is a bifunctional protein that can exist as a functional cytosolic aconitase, interconverting citrate and isocitrate, or as an apoprotein that binds IREs. Studies indicate that the active site cleft responsible for aconitase activity overlaps extensively with the region that binds to IREs. Thus, IRP1 is bifunctional, and the ratio of the holoprotein and apoprotein forms most likely determines the way IRP1 functions in cells. Instability of the iron-sulfur prosthetic group may be a key determinant of the ratio between holoprotein and apoprotein. Numerous enzymes and proteins facilitate iron-sulfur cluster assembly and formation of active cytosolic aconitase. (b) Left, the IRP1 structure with its cluster; right, IRP1 modeled with the IRE bound. Structures are depicted according to the recently solved holoprotein structure46; illustrations created by J. Dupuy. Domains are labeled; domains 1–3 are connected to domain 4 by a flexible hinge linker (black) that is depicted as seen in the crystal structure (left) or in a conformation that could accommodate the IRE, based on structural modeling (right) in which the position of domain 4 is moved to accommodate the IRE within an enlarged cleft. Domain 4 (655–889) Some IRP1s may lack function as either a cytosolic aconitase or an IRE binding protein80, but the physiologic relevance and size of this functionless pool of IRP1 is not yet clear. Nitration of IRP1 in activated macrophages leads to inactivation of the aconitase and IRE binding activities of IRP1 without causing degradation81. In addition, iron-dependent degradation of IRP1 occurs in some cells and can be enhanced by phosphorylation at Ser138 (ref. 78), thereby providing a potential link between growth signaling pathways and IRP1 activity. Phosphorylation of IRP1 at Ser711 can also modulate aconitase activity in vivo82,83. Thus, various factors that do not directly affect iron-sulfur cluster assembly and disassembly may modify operation of the iron-sulfur switch. The role of IRP1 in mammalian physiology Because IRP1 is abundant in animal tissues and regulates its IRE binding activity in tissue culture and in rats subjected to iron depletion84, investigators have assumed that IRP1 is important in intracellular iron regulation. However, genetic ablation studies have revealed that the homologous protein, IRP2, is important in the regulation of iron metabolism in mice85,86, whereas ablation of IRP1 has little effect on regulation of tissue iron homeostasis, except in kidney and brown fat, in which IRP1 expression is very high87. Unlike in cells grown in room air, most IRP1 in animal tissues is in the aconitase form, and IRP1 does not convert to the IRE-binding form in cells given a low-iron diet that is sufficient to activate IRP2 (ref. 87).Even when IRP2 is absent, IRP1 binding activity does not increase, whereas when IRP1 is absent, IRP2 binding activity and concentration increases in a compensatory fashion87,88. Thus, it seems that the primary physiologic role of IRP1 may be to function as a cytosolic aconitase. By interconverting citrate and isocitrate in the cytosol, cytosolic aconitase may allow cells to balance the amount of reduced nicotinamide adenine dinucleotide phosphate (NADPH) generated by cytosolic isocitrate dehydrogenase with the amount of acetyl coenzyme A generated from cytosolic citrate by the citrate lyase reaction. Fatty acid synthesis requires (i) the acetyl coenzyme A building blocks 410 derived from citrate and (ii) NADPH, which is generated by cytosolic isocitrate dehydrogenase when it catalyzes conversion of isocitrate to 2-oxoglutarate. Recent studies indicate that cytosolic isocitrate dehydrogenase is one of the main sources of NADPH in mammalian cells89. In energy-rich cells, large NADH to NAD+ ratios repress mitochondrial isocitrate dehydrogenase activity90, leading to accumulation of citrate and isocitrate in the mitochondrial matrix and driving export of these citric acid intermediates to the cytosol through the tricarboxylic acid transporter, where they can serve as fatty acid precursors91. Notably, IRP1 is most highly expressed in brown fat, liver, kidney and testicular epididymal cells, potentially important sites for energy storage and fatty acid synthesis. The difference between the potential of IRP1 to regulate iron metabolism and its actual role in animals is most likely attributable to the role of oxygen in destabilizing iron-sulfur clusters. In tissue culture, cells are usually exposed to the high atmospheric oxygen concentrations of room air, whereas in animals, oxygen concentrations are much lower, in the range of 3–6%88. IRP1 provides most of the IRE binding activity detected in cells grown in room air, whereas IRP1 converts to the cytosolic aconitase form at the low oxygen tensions that prevail in mammalian tissues and is less important than IRP2 in regulation of iron metabolism (Fig. 6). Thus, turnover of the labile iron-sulfur cluster is likely to be markedly lower in animal tissues than in tissue culture cells, and cluster turnover in animal tissues may depend more on the reactive oxygen species and nitric oxide produced by stimuli such as infection and inflammation53. Role of IRP2 in regulation of iron metabolism IRP2 is a ubiquitously expressed regulatory protein that has a central role in mammalian iron metabolism85,86. Mice that lack IRP2 develop anemia due to insufficient erythroid expression of TfR, which combines with overexpression of ferritin to deplete cells of iron that is needed for heme synthesis. IRP2−/− mice do not appropriately repress translation of eALAS, which has an IRE at its 5′ end; consequently, they produce 200-fold more VOLUME 2 NUMBER 8 AUGUST 2006 NATURE CHEMICAL BIOLOGY PERSPECTIVE of the porphyrin heme precursor protoporphyISCS rin IX than do wild-type mice25. In adulthood, O −/− mice develop progressive neurodegenIRP2 O erative disease associated with degeneration of NH axons followed by death of neuronal cell bodies S from cysteine in cells that overexpress ferritin and synthesize S-ISCS too little TfR85,92,93. Anemia without progressive neurodegeneration has been reported in HSCA, HSCB? one IRP2−/− mouse model86, but neurodegenTarget protein eration is most likely the primary consequence Frataxin? Fe FDX, GRX? of IRP loss, given that both neurodegeneration HSCA, HSCB? and anemia are exacerbated in IRP1+/− IRP2−/− mice compared with IRP2−/− mice (Fig. 7a–f)92, a result indicating that IRP1 and IRP2 function HSCA, HSCB? in the same pathway and that there is a gene ISCU/NFU/ISCA Target protein dosage effect. Although IRP1 and IRP2 are equally able to regulate ferritin translation in vitro94 and are Figure 5 Proposed schematic of mammalian iron-sulfur cluster assembly. The cysteine desulfurase both ubiquitously expressed, IRP2 dominates ISCS generates sulfur, which it donates to ISCU. ISCU binds iron, perhaps donated by frataxin, and regulation of iron homeostasis87. The reason serves as a scaffold on which nascent iron-sulfur clusters are assembled. ISCA and NFU may also for this domination is likely to be intimately function as scaffold proteins. Ferredoxin (FDX) and glutaredoxin 5 (GRX) provide reducing equivalents, related to IRP2’s unique mechanism for sens- and the chaperones HSCA and HSCB (heat shock cognate proteins A and B, respectively) are likely to ing and regulating iron concentrations. In iron- enhance scaffold folding and transfer of clusters to recipient apoproteins such as IRP1 (refs. 63,64). replete cells, IRP2 is efficiently degraded in an iron-dependent manner, and its concentration is not regulated by an iron-sulfur switch17,41,42. In addition, cells acti- is also possible, but unlikely, that IRP2 transiently assembles an ironvated by expression of the c-myc oncogene increase expression of IRP2 sulfur cluster17. mRNA, indicating that regulation of IRP2 expression may be affected by A critical feature that allows IRP2 to predominate in the regulation of the growth status of cells95. Thus, regulation of transcription and protein iron metabolism is IRP2’s relative stability and IRE-binding activity at the low oxygen concentrations that prevail in mammalian tissues. IRP1, in turnover most likely affect IRP2 expression. contrast, is mainly active as an aconitase at these low oxygen concentrations (Fig. 6). Another important difference is that IRP2 can compensate Mechanism of iron-dependent degradation of IRP2 The mechanism by which IRP2 undergoes iron-dependent degrada- for loss of IRP1 (ref. 88), perhaps because loss of IRP1 results in mild iron tion is incompletely understood. Relative to IRP1, IRP2 contains an deficiency due to minor decreases in TfR expression and increases in ferextra cysteine-rich exon. Previously referred to as the iron-dependent ritin, and decreased cytosolic iron concentrations partially stabilize IRP2. degradation domain, this exon has been thought to be responsible for Though recent data on regulation of ISCU indicate that iron deficiency characteristic iron-dependent degradation owing to its ability to facili- decreases cellular ISCU expression and may thereby reduce the amount tate iron-dependent oxidation96, ubiquitination and proteasomal deg- of IRP1 that has an iron-sulfur cluster65, regulation of iron-sulfur cluster radation97,98. However, the initial steps in iron-dependent degradation assembly proteins has yet to be characterized in intact animals. of IRP2 are not well characterized, and the role of the iron-dependent degradation domain has been questioned99,100. Other molecules or fac- The physiologic importance of the IRE-IRP regulatory system tors that may signal the iron-replete state and facilitate degradation of Developing embryos that lack both copies of IRP1 and IRP2 die at the IRP2 include heme100–103, 2-oxoglutarate–dependent oxygenases99,104 blastocyst stage, before implantation106. This embryonic lethality of the and phosphorylation status105, and the contribution of various pathways IRP1−/− IRP2−/− genotype underscores the fact that the IRP-IRE regulato IRP2 degradation may depend in part on the cells involved103. It is tory system is critical for regulation of iron metabolism and that IRP1 possible that IRP2 has evolved to ‘sense’ cytosolic iron concentrations and IRP2 have redundant functions. Their redundancy is further underthrough multiple pathways: direct binding of iron or heme, as well as scored by the fact that the neurodegeneration and anemia of IRP2−/− activation of cytosolic oxygenases, may combine to robustly target IRP2 mice is greatly exacerbated in animals that also lack at least one copy for ubiquitination and proteasomal degradation in iron-replete cells. It of IRP1 (Fig. 7)25,92. The gene dosage effect of IRP loss is illustrated by – + Figure 6 IRP2 has greater IRE-binding activity than IRP1 at the characteristically low oxygen concentrations found in mammalian tissues. At these low oxygen concentrations IRP2 is highly active as an IRE-binding protein, whereas IRP1 acts mainly as a cytosolic aconitase and has low IRE binding activity. The schematic shows IRP binding activity over a range of oxygen concentrations, along with markings that indicate the reported mammalian tissue oxygen concentrations of bone marrow, spleen and brain (yellow arrows). The oxygen concentrations of many other tissues are between 3% and 6% (the area between the two vertical black arrows on the x axis), whereas most cells grown in traditional tissue culture flasks are exposed to oxygen concentrations closer to the 21% oxygen concentration of room air. NATURE CHEMICAL BIOLOGY VOLUME 2 NUMBER 8 AUGUST 2006 IRE binding activity © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology 3 IRP1-IRE binding activity 1% Bone marrow Spleen Brain Oxygen concentration 21% Tissue culture 411 PERSPECTIVE Wild type IRP2–/– IRP2–/– IRP1+/– a b c d e f © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology Ferric staining Axonal degeneration 2 mm IRP2–/– Wild type g h Toluidine blue 10 µM Figure 7 Neurodegeneration in adult IRP2−/− and IRP1+/− IRP2−/− animals is characterized by ferric iron accumulations in distinctive white-matter areas of the brain and by axonal degeneration in the affected white-matter areas. (a–f) Coronal sections of whole mouse brains through the cerebellum show little ferric iron accumulation or axonal degeneration in wild-type mice (a,d). However, ferric iron accumulations (golden-brown stain in a–c) are present in IRP2−/− mice (b) and are markedly increased in IRP2−/− IRP1+/− mice (c), and there is concomitant axonal degeneration in IRP2−/− mice (e), which is more marked in IRP2−/− IRP1+/− mice (f), as indicated by deposition of black thread-like silver deposits within white matter in degenerating axons. A green counterstain for nuclei heavily stains regions that are rich in cell bodies (traditional gray matter) in a–c, whereas a red nuclear counterstain is used in d–f to allow visualization of distinctive landmarks near the back of the brain, particularly the cerebellar folia. (g,h) In brain tissue fixed in epoxy and stained with toluidine blue for improved morphologic visualization at high magnification, myelin-dense bodies indicative of axonal degeneration are commonly found (arrow) in IRP2−/− (h) but not in wild-type mice (g). In this stain, normal axons appear as blue rings with white centers; the thick blue rim represents the myelin sheath, whereas the white center represents the normal axon. Myelin-dense bodies are created when axons degenerate and the myelin sheath collapses to fill the space formerly occupied by an axon. Figures reproduced from ref. 92 with permission from Blackwell Publishing. ferric iron accumulations, which are detectable in many axon-rich regions of the brain in 1-year-old IRP2−/− mice (Fig. 7c) and are pronounced in age-matched IRP1+/− IRP2−/− mice (Fig. 7e) but are not detectable in agematched wild-type mice (Fig. 7a). The ferric iron is most likely sequestered by ferritin and is relatively inaccessible, even though increased ferric iron staining is usually thought to signify increased iron availability85,92. In cells, the combination of ferritin overexpression with decreased TfR1 expression may result in a state of functional iron deficiency that adversely affects axons, which depend on iron-replete mitochondria to generate the ATP that supports axonal transport and function. Notably, axons in white matter areas of the brain that accumulate ferric iron show degeneration, as evidenced by a special staining procedure known as the amino cupric silver stain, in which black deposits of silver are observed in IRP2−/− and IRP1+/− IRP2−/− brains (Fig. 7e,f)92. Intact axons of the 412 wild type prevent penetration of silver (Fig. 7b), whereas degenerating axons allow the silver to penetrate and bind to negatively charged neurofilaments, creating threadlike black deposits that follow the course of axons. Ultimately, complete loss of axonal integrity results in collapse of the myelin sheath around axonal remnants in mutant mice (Fig. 7h), but not in wild-type mice (Fig. 7g). Notably, animals having some residual IRP activity (IRP1+/− IRP2−/− animals) can survive to adulthood with apparent functional compromise of only the hematopoietic and neurologic systems, whereas other cells and tissues are spared. In neurons, swelling and inflammation initially affects axons, but ultimately neuronal cell bodies die, particularly in the substantia nigra, the area of the brain affected in Parkinson disease92. The cause of neuronal dysfunction and death is not yet clear, but based on an analogy to erythroid cells, it is possible that iron deficiency may adversely VOLUME 2 NUMBER 8 AUGUST 2006 NATURE CHEMICAL BIOLOGY PERSPECTIVE © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology affect neurons by compromising synthesis of the iron-sulfur complexes of the mitochondrial respiratory chain. The fact that IRP2 loss causes adult-onset neurodegenerative disease with Parkinsonian features raises the possibility that IRP2 dysfunction will prove to be a cause of adult-onset human neurodegenerative disease. Affected individuals carrying IRP2 mutations are also likely to have microcytic anemia and elevated red cell protoporphyrin IX concentrations, although the movement disorder and anemia can be very subtle if only one IRP2 allele is inactivated85. Future directions Animal studies indicate that the IRP-IRE regulatory system is important in physiology. Future studies are likely to bring more knowledge about mammalian iron-sulfur cluster assembly and the factors that operate the iron-sulfur cluster switch of IRP1. Much remains to be determined about the mechanisms by which IRP2 is targeted for iron-dependent degradation and those by which IRP transcription is affected by growth signals. The neurodegeneration of IRP2−/− mice provides a useful model in which the causes of neuronal death can be dissected. If functional iron deficiency causes mitochondrial dysfunction, which in turn causes free radical stress and failure of energy production in axons, this central insight may provide understanding of the pathophysiology of many neurodegenerative diseases in which iron misregulation is suspected to have a role. ACKNOWLEDGMENTS I thank J. Dupuy for drawing the figure of IRP1, modeling the IRP1-IRE interaction and generously sharing his insights about IRP1 structure, W.H. Tong for creating the iron-sulfur cluster biogenesis schematic and my scientific colleagues for their excellent work and help. This work was supported by the intramural program of the National Institute of Child Health and Human Development. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Published online at http://www.nature.com/naturechemicalbiology/ Reprints and permissions information is available online at http://npg.nature.com/ reprintsandpermissions/ 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. Hentze, M.W., Muckenthaler, M.U. & Andrews, N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117, 285–297 (2004). Ganz, T. Hepcidin in iron metabolism. Curr. Opin. Hematol. 11, 251–254 (2004). Aisen, P. Transferrin, the transferrin receptor, and the uptake of iron by cells. Met. Ions Biol. Syst. 35, 585–631 (1998). Aisen, P. Transferrin receptor 1. Int. J. Biochem. Cell Biol. 36, 2137–2143 (2004). Harrison, P.M. & Arosio, P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161–203 (1996). Rouault, T. & Klausner, R. Regulation of iron metabolism in eukaryotes. Curr. Top. Cell. Regul. 35, 1–19 (1997). Pantopoulos, K. Iron metabolism and the IRE/IRP regulatory system: an update. Ann. NY Acad. Sci. 1012, 1–13 (2004). Klausner, R.D., Rouault, T.A. & Harford, J.B. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72, 19–28 (1993). Gruer, M.J., Artymiuk, P.J. & Guest, J.R. The aconitase family: three structural variations on a common theme. Trends Biochem. Sci. 22, 3–6 (1997). Beinert, H., Kennedy, M.C. & Stout, D.C. Aconitase as iron-sulfur protein, enzyme, and iron-regulatory protein. Chem. Rev. 96, 2335–2373 (1996). Addess, K.J., Basilion, J.P., Klausner, R.D., Rouault, T.A. & Pardi, A.J. Structure and dynamics of the iron responsive element RNA: implications for binding of the RNA by iron regulatory proteins. J. Mol. Biol. 274, 72–83 (1997). Gdaniec, Z., Sierzputowska-Gracz, H. & Theil, E.C. Iron regulatory element and internal loop/bulge structure for ferritin mRNA studied by cobalt(III) hexammine binding, molecular modeling, and NMR spectroscopy. Biochemistry 37, 1505–1512 (1998). Dix, D.J., Lin, P.N., McKenzie, A.R., Walden, W.E. & Theil, E.C. The influence of the base-paired flanking region on structure and function of the ferritin mRNA iron regulatory element. J. Mol. Biol. 231, 230–240 (1993). Allerson, C.R., Cazzola, M. & Rouault, T.A. Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J. Biol. Chem. 274, 26439–26447 (1999). NATURE CHEMICAL BIOLOGY VOLUME 2 NUMBER 8 AUGUST 2006 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. Henderson, B.R., Menotti, E. & Kuhn, L.C. Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences. J. Biol. Chem. 271, 4900–4908 (1996). Butt, J. et al. Differences in the RNA binding sites of iron regulatory proteins and potential target diversity. Proc. Natl. Acad. Sci. USA 93, 4345–4349 (1996). Meehan, H.A. & Connell, G.J. The hairpin loop but not the bulged C of the iron responsive element is essential for high affinity binding to iron regulatory protein-1. J. Biol. Chem. 276, 14791–14796 (2001). Menotti, E., Henderson, B.R. & Kuhn, L.C. Translational regulation of mRNAs with distinct IRE sequences by iron regulatory proteins 1 and 2. J. Biol. Chem. 273, 1821–1824 (1998). Ke, Y., Wu, J., Leibold, E.A., Walden, W.E. & Theil, E.C. Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Finetuning of mRNA regulation. J. Biol. Chem. 273, 23637–23640 (1998). Theil, E.C. & Eisenstein, R.S. Combinatorial mRNA regulation: iron regulatory proteins and iso-iron-responsive elements (iso-IREs). J. Biol. Chem. 275, 40659– 40662 (2000). Ismail, A.R., Lachlan, K.L., Mumford, A.D., Temple, I.K. & Hodgkins, P.R. Hereditary hyperferritinemia cataract syndrome: ocular, genetic, and biochemical findings. Eur. J. Ophthalmol. 16, 153–160 (2006). Hentze, M.W. et al. Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science 238, 1570–1573 (1987). Leibold, E.A. & Munro, H.N. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl. Acad. Sci. USA 85, 2171–2175 (1988). Melefors, O. et al. Translational control of 5-aminolevulinate synthase mRNA by ironresponsive elements in erythroid cells. J. Biol. Chem. 268, 5974–5978 (1993). Cooperman, S.S. et al. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood 106, 1084–1091 (2005). Kim, H.Y., LaVaute, T., Iwai, K., Klausner, R.D. & Rouault, T.A. Identification of a conserved and functional iron-responsive element in the 5′UTR of mammalian mitochondrial aconitase. J. Biol. Chem. 271, 24226–24230 (1996). Gray, N.K., Pantopoulos, K., Dandekar, T., Ackrell, B.A. & Hentze, M.W. Translational regulation of mammalian and Drosophila citric-acid cycle enzymes via iron-responsive elements. Proc. Natl. Acad. Sci. USA 93, 4925–4930 (1996). Schalinske, K.L., Chen, O.S. & Eisenstein, R.S. Iron differentially stimulates translation of mitochondrial aconitase and ferritin mRNAs in mammalian cells. Implications for iron regulatory proteins as regulators of mitochondrial citrate utilization. J. Biol. Chem. 273, 3740–3746 (1998). Kohler, S.A., Henderson, B.R. & Kuhn, L.C. Succinate dehydrogenase b mRNA of Drosophila melanogaster has a functional iron-responsive element in its 5′-untranslated region. J. Biol. Chem. 270, 30781–30786 (1995). Abboud, S. & Haile, D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906–19912 (2000). Gunshin, H. et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482–488 (1997). Kohler, S.A., Menotti, E. & Kuhn, L.C. Molecular cloning of mouse glycolate oxidase. High evolutionary conservation and presence of an iron-responsive element-like sequence in the mRNA. J. Biol. Chem. 274, 2401–2407 (1999). Gunshin, H. et al. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett. 509, 309–316 (2001). Recalcati, S., Tacchini, L., Alberghini, A., Conte, D. & Cairo, G. Oxidative stressmediated down-regulation of rat hydroxyacid oxidase 1, a liver-specific peroxisomal enzyme. Hepatology 38, 1159–1166 (2003). Beaumont, C. et al. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat. Genet. 11, 444–446 (1995). Cazzola, M. & Skoda, R.C. Translational pathophysiology: a novel molecular mechanism of human disease. Blood 95, 3280–3288 (2000). Rouault, T.A. et al. Cloning of the cDNA encoding an RNA regulatory protein–the human iron-responsive element-binding protein. Proc. Natl. Acad. Sci. USA 87, 7958–7962 (1990). Patino, M.M. & Walden, W.E. Cloning of a functional cDNA for the rabbit ferritin mRNA repressor protein: demonstration of a tissue specific pattern of expression. J. Biol. Chem. 267, 19011–19016 (1992). Yu, Y., Radisky, E. & Leibold, E.A. The iron-responsive element binding protein: purification, cloning and regulation in rat liver. J. Biol. Chem. 267, 19005–19010 (1992). Hirling, H. et al. Expression of active iron regulatory factor from a full-length human cDNA by in vitro transcription/translation. Nucleic Acids Res. 20, 33–39 (1992). Guo, B., Yu, Y. & Leibold, E.A. Iron regulates cytoplasmic levels of a novel ironresponsive element-binding protein without aconitase activity. J. Biol. Chem. 269, 24252–24260 (1994). Samaniego, F., Chin, J., Iwai, K., Rouault, T.A. & Klausner, R.D. Molecular characterization of a second iron responsive element binding protein, iron regulatory protein 2 (IRP2): structure, function and post-translational regulation. J. Biol. Chem. 269, 30904–30910 (1994). Kaptain, S. et al. A regulated RNA binding protein also possesses aconitase activity. Proc. Natl. Acad. Sci. USA 88, 10109–10113 (1991). Kennedy, M.C., Mende-Mueller, L., Blondin, G.A. & Beinert, H. Purification and characterization of cytosolic aconitase from beef liver and its relationship to the iron-responsive element binding protein (IRE-BP). Proc. Natl. Acad. Sci. USA 89, 11730–11734 (1992). 413 PERSPECTIVE 45. 46. 47. 48. © 2006 Nature Publishing Group http://www.nature.com/naturechemicalbiology 49. 50. 51. 52. 53. 54. 55. 56. 57. 58. 59. 60. 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. 414 Zheng, L., Andrews, P.C., Hermodson, M.A., Dixon, J.E. & Zalkin, H. Cloning and structural characterization of porcine heart aconitase. J. Biol. Chem. 265, 2814– 2821 (1990). Dupuy, J. et al. Crystal structure of human iron regulatory protein 1 as cytosolic aconitase. Structure 14, 129–139 (2006). Robbins, A.H. & Stout, C.D. The structure of aconitase. Proteins 5, 289–312 (1989). Hirling, H., Henderson, B.R. & Kuhn, L.C. Mutational analysis of the [4Fe-4S]-cluster converting iron regulatory factor from its RNA-binding form to cytoplasmic aconitase. EMBO J. 13, 453–461 (1994). Philpott, C.C., Klausner, R.D. & Rouault, T.A. The bifunctional iron-responsive element binding protein/cytosolic aconitase: the role of active-site residues in ligand binding and regulation. Proc. Natl. Acad. Sci. USA 91, 7321–7325 (1994). DeRusso, P.A. et al. Expression of a constitutive mutant of iron regulatory protein 1 abolishes iron homeostasis in mammalian cells. J. Biol. Chem. 270, 15451–15454 (1995). Wang, J. & Pantopoulos, K. Conditional derepression of ferritin synthesis in cells expressing a constitutive IRP1 mutant. Mol. Cell. Biol. 22, 4638–4651 (2002). Rouault, T.A. & Klausner, R.D. Iron-sulfur clusters as biosensors of oxidants and iron. Trends Biochem. Sci. 21, 174–177 (1996). Cairo, G., Recalcati, S., Pietrangelo, A. & Minotti, G. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic. Biol. Med. 32, 1237–1243 (2002). Bouton, C. & Drapier, J.C. Iron regulatory proteins as NO signal transducers. Sci. STKE 2003, pe17 (2003). Caltagirone, A., Weiss, G. & Pantopoulos, K. Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J. Biol. Chem. 276, 19738–19745 (2001). Haile, D.J. et al. Cellular regulation of the iron-responsive element binding protein: disassembly of the cubane iron-sulfur cluster results in high affinity RNA binding. Proc. Natl. Acad. Sci. USA 89, 11735–11739 (1992). Basilion, J.P., Rouault, T.A., Massinople, C.M., Klausner, R.D. & Burgess, W.H. The iron-responsive element-binding protein: localization of the RNA binding site to the aconitase active-site cleft. Proc. Natl. Acad. Sci. USA 91, 574–578 (1994). Kaldy, P., Menotti, E., Moret, R. & Kuhn, L.C. Identification of RNA-binding surfaces in iron regulatory protein-1. EMBO J. 18, 6073–6083 (1999). Gegout, V. et al. Ligand-induced structural alterations in human iron regulatory protein1 revealed by protein footprinting. J. Biol. Chem. 274, 15052–15058 (1999). Selezneva, A.I., Cavigiolio, G., Theil, E.C., Walden, W.E. & Volz, K. Crystallization and preliminary X-ray diffraction analysis of iron regulatory protein 1 in complex with ferritin IRE RNA. Acta Crystallograph. Sect. F Struct. Biol. Cryst. Commun. 62, 249–252 (2006). Eisenstein, R.S. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu. Rev. Nutr. 20, 627–662 (2000). Johnson, D.C., Dean, D.R., Smith, A.D. & Johnson, M.K. Structure, function, and formation of biological iron-sulfur clusters. Annu. Rev. Biochem. 74, 247–281 (2005). Lill, R. & Muhlenhoff, U. Iron-sulfur-protein biogenesis in eukaryotes. Trends Biochem. Sci. 30, 133–141 (2005). Rouault, T.A. & Tong, W.H. Opinion: iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat. Rev. Mol. Cell Biol. 6, 345–351 (2005). Tong, W.H. & Rouault, T.A. Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab. 3, 199–210 (2006). Li, K., Tong, W.H., Hughes, R.M. & Rouault, T.A. Roles of the mammalian cytosolic cysteine desulfurase, ISCS, and scaffold protein, ISCU, in iron-sulfur cluster assembly. J. Biol. Chem. 281, 12344–12351 (2006). Land, T. & Rouault, T.A. Targeting of a human iron-sulfur cluster assembly enzyme, nifs, to different subcellular compartments is regulated through alternative AUG utilization. Mol. Cell 2, 807–815 (1998). Tong, W.H. & Rouault, T. Distinct iron-sulfur cluster assembly complexes exist in the cytosol and mitochondria of human cells. EMBO J. 19, 5692–5700 (2000). Tong, W.H., Jameson, G.N., Huynh, B.H. & Rouault, T.A. Subcellular compartmentalization of human Nfu, an iron-sulfur cluster scaffold protein, and its ability to assemble a [4Fe-4S] cluster. Proc. Natl. Acad. Sci. USA 100, 9762–9767 (2003). Rodriguez-Manzaneque, M.T., Tamarit, J., Belli, G., Ros, J. & Herrero, E. Grx5 is a mitochondrial glutaredoxin required for the activity of iron/sulfur enzymes. Mol. Biol. Cell 13, 1109–1121 (2002). Molina-Navarro, M.M., Casas, C., Piedrafita, L., Belli, G. & Herrero, E. Prokaryotic and eukaryotic monothiol glutaredoxins are able to perform the functions of Grx5 in the biogenesis of Fe/S clusters in yeast mitochondria. FEBS Lett. 580, 2273–2280 (2006). Wingert, R.A. et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 436, 1035–1039 (2005). Rouault, T.A. Linking physiological functions of iron. Nat. Chem. Biol. 1, 193–194 (2005). Cairo, G., Ronchi, R., Recalcati, S., Campanella, A. & Minotti, G. Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of. Biochemistry 41, 7435–7442 (2002). Mueller, S., Pantopoulos, K., Hubner, C.A., Stremmel, W. & Hentze, M.W. IRP1 activation by extracellular oxidative stress in the perfused rat liver. J. Biol. Chem. 276, 23192–23196 (2001). 76. 77. 78. 79. 80. 81. 82. 83. 84. 85. 86. 87. 88. 89. 90. 91. 92. 93. 94. 95. 96. 97. 98. 99. 100. 101. 102. 103. 104. 105. 106. Recalcati, S. et al. Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency. Haematologica 91, 303–310 (2006). Missirlis, F. et al. Compartment-specific protection of iron-sulfur proteins by superoxide dismutase. J. Biol. Chem. 278, 47365–47369 (2003). Clarke, S.L. et al. Iron-responsive degradation of iron-regulatory protein 1 does not require the Fe-S cluster. EMBO J. 25, 544–553 (2006). Wallace, M.A. et al. Superoxide inhibits 4Fe-4S cluster enzymes involved in amino acid biosynthesis. Cross-compartment protection by CuZn-superoxide dismutase. J. Biol. Chem. 279, 32055–32062 (2004). Brown, N.M., Kennedy, M.C., Antholine, W.E., Eisenstein, R.S. & Walden, W.E. Detection of a [3Fe-4S] cluster intermediate of cytosolic aconitase in yeast expressing iron regulatory protein 1. Insights into the mechanism of Fe-S cluster cycling. J. Biol. Chem. 277, 7246–7254 (2002). Gonzalez, D., Drapier, J.C. & Bouton, C. Endogenous nitration of iron regulatory protein-1 (IRP-1) in nitric oxide-producing murine macrophages: further insight into the mechanism of nitration in vivo and its impact on IRP-1 functions. J. Biol. Chem. 279, 43345–43351 (2004). Pitula, J.S. et al. Selective inhibition of the citrate-to-isocitrate reaction of cytosolic aconitase by phosphomimetic mutation of serine-711. Proc. Natl. Acad. Sci. USA 101, 10907–10912 (2004). Fillebeen, C., Caltagirone, A., Martelli, A., Moulis, J.M. & Pantopoulos, K. IRP1 Ser711 is a phosphorylation site, critical for regulation of RNA-binding and aconitase activities. Biochem. J. 388, 143–150 (2005). Chen, O.S., Schalinske, K.L. & Eisenstein, R.S. Dietary iron intake modulates the activity of iron regulatory proteins and the abundance of ferritin and mitochondrial aconitase in rat liver. J. Nutr. 127, 238–248 (1997). LaVaute, T. et al. Targeted deletion of iron regulatory protein 2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27, 209–214 (2001). Galy, B. et al. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood 106, 2580–2589 (2005). Meyron-Holtz, E.G. et al. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 23, 386–395 (2004). Meyron-Holtz, E.G., Ghosh, M.C. & Rouault, T.A. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306, 2087–2090 (2004). Koh, H.J. et al. Cytosolic NADP+-dependent isocitrate dehydrogenase plays a key role in lipid metabolism. J. Biol. Chem. 279, 39968–39974 (2004). Lawlis, V.B. & Roche, T.E. Effect of micromolar Ca2+ on NADH inhibition of bovine kidney alpha-ketoglutarate dehydrogenase complex and possible role of Ca2+ in signal amplification. Mol. Cell. Biochem. 32, 147–152 (1980). Palmieri, F. et al. Mitochondrial metabolite transporters. Biochim. Biophys. Acta 1275, 127–132 (1996). Smith, S.R. et al. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann. NY Acad. Sci. 1012, 65–83 (2004). Zhang, P. et al. Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. J. Struct. Biol. 150, 144–153 (2005). Kim, H.Y., Klausner, R.D. & Rouault, T.A. Translational repressor activity is equivalent and is quantitatively predicted by in vitro RNA binding for two iron-responsive element binding proteins, IRP1 and IRP2. J. Biol. Chem. 270, 4983–4986 (1995). Wu, K.J., Polack, A. & Dalla-Favera, R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283, 676–679 (1999). Iwai, K. et al. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc. Natl. Acad. Sci. USA 95, 4924–4928 (1998). Iwai, K., Klausner, R.D. & Rouault, T.A. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14, 5350–5357 (1995). Guo, B., Phillips, J.D., Yu, Y. & Leibold, E.A. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J. Biol. Chem. 270, 21645–21651 (1995). Wang, J. et al. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol. Cell. Biol. 24, 954–965 (2004). Bourdon, E. et al. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2. Blood Cells Mol. Dis. 31, 247–255 (2003). Yamanaka, K. et al. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat. Cell Biol. 5, 336–340 (2003). Jeong, J., Rouault, T.A. & Levine, R.L. Identification of a heme-sensing domain in iron regulatory protein 2. J. Biol. Chem. 279, 45450–45454 (2004). Ishikawa, H. et al. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol. Cell 19, 171–181 (2005). Hanson, E.S., Rawlins, M.L. & Leibold, E.A. Oxygen and iron regulation of iron regulatory protein 2. J. Biol. Chem. 278, 40337–40342 (2003). Schalinske, K.L. & Eisenstein, R.S. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL60 cells. J. Biol. Chem. 271, 7168–7176 (1996). Smith, S.R., Ghosh, M.C., Ollivierre-Wilson, H., Hang Tong, W. & Rouault, T.A. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development. Blood Cells Mol. Dis. 36, 283–287 (2006). VOLUME 2 NUMBER 8 AUGUST 2006 NATURE CHEMICAL BIOLOGY ...
View Full Document

This note was uploaded on 05/07/2010 for the course NUTRI SCI 160 taught by Professor Hellerstein during the Spring '10 term at University of California, Berkeley.

Ask a homework question - tutors are online